2016 Speaker List

April Abbott, Ph.D., D(ABMM), Director, Microbiology, Deaconess Health System

Gyorgy Abel, M.D., Ph.D., Director, Clinical Chemistry and Molecular Diagnostics, Lahey Hospital & Medical Center

Daniel Adams, Senior Research Scientist,Creatv MicroTech,Inc

Chrystal Adams, Assistant Vice President, Product Line Management, Marketing, XIFIN, Inc.

Daniel Adlerstein, Ph.D., Director, Research and Development, Atlas Genetics Limited

Mohit Agnihotri, Associate Director, Informatics, Novartis Institutes for BioMedical Research

Ingrid Akerblom, Ph.D, Executive Director Analytics, Collaboration and User Experience, Amgen

Mary Alikian, MSc, Clinical Scientist, Imperial Molecular Pathology, Imperial College

Catherine Alix-Panabières, Ph.D., Maître de Conférence - Praticien Hospitalier, Associate Professor, Director, Laboratory of Rare Human Circulating Cells, Institute of University Clinical Research (IURC), University Medical Centre of Montpellier, University of Montpellier

Ash A. Alizadeh, Ph.D., Principal Investigator, Assistant Professor, Medicine, Divisions of Oncology & Hematology; Attending Physician, Lymphoma Oncology Clinic, Stanford Cancer Center, Stanford University

Robert A. Anders, Associate Professor, Pathology, Johns Hopkins School of Medicine; Director, Liver Pathology, Division of Gastrointestinal and Liver Pathology, Johns Hopkins Hospital

Donald Apanovitch Ph.D., Director, Functional Genomics (Oncology), Pfizer Research

Pat Arensdorf, MBA, Principal, Halteres Associates, LLC

Mara G. Aspinall, Executive Chairman, GenePeeks

Chloe E. Atreya M.D., Ph.D., Assistant Clinical Professor, Gastrointestinal Oncology Program, University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center

Steven D. Averbuch, M.D., Vice President, Translational Clinical Development & Pharmacodiagnostics, Bristol-Myers Squibb

Victoria Bae-Jump, M.D., Ph.D., Associate Professor, Division of Gynecologic Oncology, University of North Carolina

Bart Barefoot, Director, Specialty Drug Policy, US Public Policy; Policy and Advocacy Lead, Precision Medicines and Diagnostics, R&D Policy & Scientific Affairs, GSK (tentative)

Dave Barkan, Ph.D., Investigator, Infectious Diseases, Novartis Institutes for BioMedical Research

Michael Bassik, Ph.D., Assistant Professor, Department of Genetics, Stanford University

Boris C. Bastian, M.D., Ph.D., Professor, Dermatology & Pathology, Gerson and Barbara Bass Baker Distinguished Professor in Cancer Research, University of California, San Francisco

Keith Batchelder, Genomic Healthcare Strategies

Davide Bedognetti, M.D., Ph.D., Director, Tumor Biology, Immunology and Therapy, Division of Translational Medicine, Research Branch, Sidra Medical and Research Center

John Beeler, Ph.D., Vice President, Business Development, Inivata

Piraye Y. Beim, Ph.D., Founder & CEO, Celmatix Inc.

Michael F. Berger, Ph.D., Associate Director, Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center

Chetan Bettegowda, M.D., Ph.D., Assistant Professor, Neurological Surgery, Johns Hopkins University School of Medicine

Bill Biggs, Ph.D., Head, Sequencing Operations at Human Longevity, Inc.

Farideh Bischoff, Ph.D., Executive Director, Scientific Affairs, Silicon Biosystems

Christian Blumenroehr, Ph.D., Senior Scientist, Roche Innovation Center Basel, F. Hoffmann-La Roche

Xandra O. Breakefield, Ph.D., Professor, Neurology, Harvard Medical School; Geneticist, Department of Neurology and Radiology, Massachusetts General Hospital

Dirk G. Brockstedt, Ph.D., Senior Vice President, Research & Development, Aduro BioTech, Inc.

Andrew Brooks, Ph.D., COO and Director, Technology Development, Technology, RUCDR Infinite

Kenneth Buetow, Ph.D., Director of Computational Sciences and Informatics, Complex Adaptive Systems Initiative (CASI), Arizona State University

Brian Burke, Business Development Director, Horizon Diagnostics

Ben Busby, Ph.D., Genomics Outreach Coordinator, NCBI, NIH

Atul J. Butte, M.D., Ph.D., Director, Institute for Computational Health Sciences; Professor, Pediatrics, University of California, San Francisco

Lisa H. Butterfield, Ph.D., Professor, Medicine, Surgery and Immunology; Director, UPCI Immunologic Monitoring and Cellular Products Laboratory, University of Pittsburgh

Roberto Campos-Gonzalez, Ph.D., GPB Scientific

Martina Canestraro, Ph.D., Scientist, Cell biology, Immunocore Limited

Alan B. Carter, Consultant, Sales Performance International

C. Thomas Caskey, M.D., FACP, FACMG, FRSC, Professor, Molecular & Human Genetics, Baylor College of Medicine

Mark Chance, Ph.D., Professor and Director, Center for Mass Spectrometry & Proteomics, Case Western Reserve University

Ken CN Chang, Ph.D., Senior Principal Scientist, Translational Biomarkers, Merck Research

Rong Chen, Ph.D., Assistant Professor and Director of Clinical Genome Informatics, Department of Genetics and Genomic Sciences, Icahn Institute of Genomics and Multiscale Biology

Wendy Chung, M.D., Associate Professor, Clinical Genetics Program, Columbia University

Anderson Clark, Ph.D., Director, In vivo Pharmacology, Oncology, EMD Serono Research & Development

Matthew A. Coleman, Ph.D., Physics and Life Sciences, BBTD, L-452, Lawrence Livermore National Laboratory

Bruce R. Conklin, M.D., Investigator, Roddenberry Center for Stem Cell Biology and Medicine, Gladstone Institutes and Professor, Division of Genomic Medicine University of California, San Francisco

Christopher Connelly, Ph.D., Research and Development Scientific Manager, Molecular Technology, Streck

Bill Cook, President, WECA

Peter Covitz, Ph.D., Senior Director, Information Strategy and Analytics, Clinical Informatics and Innovation, Pfizer

Ian A. Cree, Ph.D., Professor, Pathology, University Hospitals Coventry and Warwickshire and Coventry University

Gail B. Croall, M.D., FAAP, CMO, HealthSpot

Mark E. Curran, Ph.D., Vice President, Immunology, Systems Pharmacology & Biomarkers, Immunology Therapeutic Area, Janssen Research & Development

Bob Daber, Ph.D., Vice President, Genomics Operations and Development, Laboratory Medicine, Bio Reference Laboratories

Peter J. Dailey, Ph.D., MPH, Senior Technical Officer, FIND (Foundation for Innovative New Diagnostics)

William S. Dalton, Ph.D., M.D., CEO, M2Gen; Director, The DeBartolo Family Personalized Medicine Institute at Moffitt Cancer Center

Stephen Dann, Ph.D., Principal Scientist, Pfizer Oncology Research Unit

Brady Davis, Senior Director Strategy & Market Development, Illumina

Ronald W. Davis, Ph.D., Professor of Biochemistry and Genetics, Director, Stanford Genome Technology Center, Stanford University

Ramana V. Davuluri, Ph.D., Professor, Preventive Medicine; Director of Cancer Informatics Core, Robert H Lurie Comprehensive Cancer Center; Department of Preventive Medicine – Division of Health and Biomedical Informatics, Northwestern University Feinberg School of Medicine

Jérôme A. Denis, MD, PhD, Sorbonne Universités

Luis A. Diaz, M.D., Associate Professor, Oncology, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

Paul Diehl, Ph.D. Director of Business Development, Cellecta, Inc.

Jennifer Dien Bard, Director of the Clinical Microbiology Laboratory, Assistant Professor of Clinical Pathology, Keck School of Medicine of the University of Southern California

Maximilian Diehn M.D., Ph.D., Assistant Professor, Radiation Oncology, Stanford University

Paul J. (Paulus Joannes) van Diest, M.D., Ph.D., Professor & Head, Pathology, University Medical Center Utrecht

John Doench, Ph.D., Associate Director, Genetic Perturbation Platform, Broad Institute of Harvard and MIT

Thomas W. Dubensky, Jr., Ph.D., CSO, Aduro Biotech

Jessica Dunne, Painter & Artist, San Francisco Bay Area

Mathias Ehrich, Ph.D., Senior Vice President, Research & Development, Sequenom, Inc.

Michael H. Elliott, CEO, Atrium Research & Consulting, LLC

Kenneth Emancipator, M.D., Executive Medical Director, Molecular Biomarkers and Diagnostics, Merck Research Laboratories

Mark G. Erlander, Ph.D., CSO, Trovagene

Daniel H. Farkas, Ph.D., HCLD, FACB, Laboratory Director, Sequenom Center for Molecular Medicine

Todd A. Fehniger, M.D., Ph.D., Associate Professor, Department of Medicine, Oncology Division, Bone Marrow Transplantation & Leukemia Section, Washington University School of Medicine

Bonnie Feldman, Ph.D., Chief Growth Officer and CEO, DrBonnie360

Lauren Feldman, MHA, Senior Terminology and Strategy Consultant, American Medical Association (AMA)

Xin Feng, Ph.D., Assistant Professor, Bioinformatics Research Lab and Department of Molecular and Human Genetics, Baylor College of Medicine

Helen Fernandes, Ph.D., Director, Molecular Pathology, Pathology & Laboratory Medicine, Weill Cornell Medical College

Joseph Ferrara, President, Boston Healthcare Associates

Kyle Fetter, Vice President, Advanced Diagnostics, XIFIN, Inc.

David Flockhart, M.D., Ph.D., Chief, Division of Clinical Pharmacology, Indiana University School of Medicine

Bernard A. Fox, Ph.D., Harder Family Chair for Cancer Research, Member & Chief, Laboratory of Molecular & Tumor Immunology, Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Providence Portland Medical Center; CEO, UbiVac

Jean-François Mirjolet, Technology Director, Oncodesign

Gus Frangou Director of Clinical Operations Cellecta

Kristopher Frese, Ph.D., Postdoctoral Fellow, University of Manchester

Lyssa Friedman, Consultant, Lyssa Friedman Consulting, LLC

Zhiyan Fu, Ph.D., CSCO, Scientific and Research Computing, Genome Institute of Singapore

Birgit H. Funke, Ph.D., FACMG, Associate Professor, Pathology, MGH/Harvard Medical School; Director, Clinical Research and Development, Laboratory for Molecular Medicine - Partners HealthCare

Joshua Galanter, M.D., Assistant Professor, Medicine, University of California, San Francisco

David Gandara, M.D., Professor, Medicine, Division of Hematology/Oncology, University of California, Davis School of Medicine; Director, Thoracic Oncology Program, Senior Advisor to the Director, University of California, Davis Comprehensive Cancer Center; Chair, Lung Committee, Southwest Oncology Group (SWOG)

Russell Garlick, Ph.D., CSO, SeraCare Life Sciences

Dimitra Georganopoulou, Ph.D., Innovation and Commercialization Officer, INVO (Innovations and New Ventures Office, Northwestern University)

Elad Gil, Ph.D., CEO, Color Genomics

Neal Goodwin, Vice President, Corporate Research & Development, Champions Oncology

Tobias M. Gorges, Ph.D., Senior Scientist, Tumor Biology, Center of Experimental Medicine, University Medical Center Hamburg-Eppendorf

Martin R. Graf, Ph.D., Associate Director, Research, Operations, Charles River Laboratories

Jeremy R. Graff, Ph.D., Senior Vice President, Research, Pharmaceutical Group, Biothera, Inc.

Daniel S. Grosu, M.D., M.B.A., CMO, Sequenom, Inc..

Zhenglong Gu, Ph.D., Assistant Professor, Division of Nutritional Sciences, Cornell Center for Comparative and Population Genomics, Cornell University

Jill Hagenkord, M.D., CMO, 23andMe

Juergen Hammer, Ph.D., Head of Pharma Research and Early Development Informatics & IT, Roche Translational and Clinical Research Center

Byron C. Hann, M.D., Ph.D., Associate Researcher, Manager of Preclinical Therapeutics Core, University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center

John W. Hanna, MBA, Vice President, Endocrinology, Veracyte, Inc.

Josephine N. Harada, Associate Director, Alliances, Illumina

Timothy Harkins, President & CEO, Swift Biosciences

Erol Harvey, Ph.D., CEO, MiniFAB

David Haussler, Ph.D., Distinguished Professor and Scientific Director, UC Santa Cruz Genomics Institute, University of California, Santa Cruz

Brian Haynes, Ph.D., Senior Scientist, Computational Biology, Manager, Bioinformatics, Asuragen

Joe Don Heath, Vice President, Market Development Diagnostics, NuGEN Technologies

Guido Hennig, Ph.D., Senior Global Scientific Affairs Manager, BU Molecular Global Marketing, Siemens Healthcare Diagnostics

Stephen M. Hewitt, M.D., Ph.D., Clinical Investigator; Head, Experimental Pathology and Lab of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, FDA

David R. Hillyard, M.D., Medical Director, Molecular Infectious Diseases, Arup Laboratories

Jens Hoefkens, Ph.D., Director, Strategic Marketing, PerkinElmer

Noah Hoffman, M.D., Ph.D., Associate Professor, University of Washington, Department of Laboratory Medicine, Associate Director, Informatics Division, University of Washington Medical Center

Robert M. Hoffman, Ph.D., President, AntiCancer, Inc.; Professor, Surgery, University of California, San Diego

Eric C. Holland, M.D., Ph.D., Senior Vice President, Director, Human Biology, Solid Tumor Translational Research, Nancy and Buster Alvord Brain Tumor Center, Fred Hutchinson Cancer Research Center, University of Washington

Andrew J. Hollinger, Application Scientist, Broad Genomics Platform, Broad Institute

Dave S.B. Hoon, Ph.D., Director, Molecular Oncology and Sequencing Center, John Wayne Cancer Institute, Providence Health Care

Jim Huggett, B.Sc. (Hons), Ph.D., Science Leader, Nucleic Acid Metrology, Molecular & Cell Biology, LGC

Romney M. Humphries, Ph.D., D(ABMM), Assistant Professor, UCLA Pathology & Laboratory Medicine, Section Chief of Clinical Microbiology, David Geffen School of Medicine, University of California, Los Angeles

Jeff T. Hutchins, Ph.D., Vice President, Preclinical Research, Peregrine Pharmaceuticals

James Inglese, Ph.D., Head Assay Development & Screening Technologies, National Center for Advancing Translational Sciences and Adjunct Investigator National Human Genome Institute

Daniel Irimia, M.D., Ph.D., Assistant Professor, Division of Surgery, Science & Bioengineering, Massachusetts General Hospital and Harvard Medical School; Associate Director, BioMEMS Resource Center

Yuval Itan, Ph.D., MRes, Postdoctoral Associate, Human Genetics of Infectious Diseases, The Rockefeller University

David Jackson, Ph.D., Chief Innovations Officer, Innovations Management, Molecular Health

Manu Jain, M.D., Assistant Attendee Optical Imaging Specialist, Dermatology, Memorial Sloan Kettering Cancer Centre (MSKCC)

Hanlee Ji, M.D., Assistant Professor, Medicine (Oncology), Stanford School of Medicine

Loren J. Joseph, M.D., Director, Molecular Diagnostics Lab, Pathology, Beth Israel Deaconess Medical Center

Raghu Kalluri, M.D., Ph.D., Professor & Chair, Cancer Biology, MD Anderson Cancer Center

Chris Karlovich, Ph.D., Principal Scientist, Molecular Diagnostics, Clovis Oncology

Marcia Kean, Chairman, Strategic Initiatives, Feinstein Kean Healthcare

James G. Keck, Ph.D., Senior Director, Clinical Lab & In Vivo Pharmacology Services, The Jackson Laboratory

Greg Keenan, M.D., Vice President, Medical Affairs & US Head Medical Officer, AstraZeneca

Shana Kelley, Ph.D., Professor, Biochemistry, University of Toronto

Anthony R. Kerlavage, Ph.D., Chief, Cancer Informatics Branch, Center for Biomedical Informatics & Information Technology, National Cancer Institute

Purvesh Khatri, Ph.D., Assistant Professor, Stanford Institute for Immunity, Transplantation and Infection (ITI), Stanford Center for Biomedical Informatics Research (BMIR), Department of Medicine, Stanford University

James Killeen, M.D., Clinical Director of Informatics Fellowship, Associate Director Information Services, Director Beach Program, University of California San Diego Department of Emergency Medicine

Michael R. King, Ph.D., Daljit S. and Elaine Sarkaria Professor of Biomedical Engineering, Meinig School of Biomedical Engineering, Cornell University

Stephen F. Kingsmore, MB, ChB, BAO, DSc, FRCPath, Dee Lyons/Missouri Endowed Chair in Genomic Medicine, University of Missouri - Kansas City; Executive Director, Medical Panomics, Children's Mercy Hospital

Roger D. Klein, M.D., J.D., Chair, Professional Relations Committee, Association for Molecular Pathology (AMP); Medical Director, Molecular Oncology, Cleveland Clinic

Christiaan Klijn, Ph.D., Computational Biology, Genentech

Michael E. Klepser, Pharm.D., FCCP, Professor, Pharmacy Practice, Ferris State University College of Pharmacy

Andrzej Kloczkowski, Ph.D., Professor, Battelle Center for Mathematical Medicine, The Research Institute at Nationwide Children's Hospital and Department of Pediatrics, The Ohio State University College of Medicine

Farida Kopti, Ph.D., Director, Chemistry/Pharmacology/HTS Informatics & IT, Merck & Co., Inc.

Casey Kozlowski, RPh, MBA, Director, Diagnostic Testing Product Development, Walgreens

Savitri Krishnamurthy. M.D., Professor, Pathology, The University of Texas MD Anderson Cancer Center

Raj, Ph.D., CEO, Biological Dynamics, Inc.

Winston Patrick Kuo, Assistant Professor, Developmental Biology, Harvard School of Dental Medicine; Director, Harvard Catalyst - LITT, Harvard Medical School

Eric Lai, Senior Vice President and Head, Pharmacogenomics, Companion Diagnostics, Takeda Development Centers of America

Hugo Lam, Senior Director of Bioinformatics, Research & Development, Bina Technologies

Julie E. Lang, M.D., FACS, Associate Professor, Breast and Soft Tissue Surgery, Norris Comprehensive Cancer Center, University of Southern California

Raymond J. Langley, Ph.D., Assistant Professor, Department of Pharmacology, University of South Alabama

David Largaespada, Ph.D., CSO, Surrogen, Inc.

Ted A. Laurence, Ph.D., Materials Science Division, Physics and Life Sciences, Lawrence Livermore National Laboratory

Martin Leach, Ph.D., Vice President R&D IT, Alexion Pharmaceuticals

Rebecca Leary, Ph.D., Lab Head and Research Investigator, Genomics Group, Next Generation Diagnostics, Novartis

Nathan A. Ledeboer, Ph.D., D(ABMM), Assistant Professor, Medical Director, Clinical Microbiology, Medical College of Wisconsin

Katya Ledin, Ph.D., MPH, Director, Napa-Solano-Yolo-Marin County Public Health Laboratory

L. James Lee, Ph.D., Helen C. Kurtz Chair, Chemical & Biomolecular Engineering, Ohio State University

David S. Lester, Ph.D., CEO, Management, NIESM Pty Ltd.

Bruce Levy, M.D., CPE, Associate Professor, Pathology, University of Illinois, Chicago; Associate Chief Health Information Officer, University of Illinois at Chicago Hospital and Health Sciences System

Sabrina Li, CEO, Coyote Bioscience

Xueying Sharon Liang, M.D., Ph.D., Regulatory Scientist, Division of Molecular Genetics and Pathology, OIR/CDRH, FDA

J. Leonard Lichtenfeld, M.D., MACP, Deputy CMO, American Cancer Society, Inc.

Michael Liebman, Ph.D., Managing Director, IPQ Analytics, LLC

John C. Lin, Ph.D., Senior Vice President & CSO, Cancer Immunotherapy, Pfizer

Xing-Jian Lou, Ph.D, Program Director, SBIR Development Center, National Cancer Institute

Elaine Lyon, Ph.D., Medical Director, Molecular Genetics, ARUP; AMP 2014 President and Member, AMP Professional Relations Committee

James Lyons-Weiler, Ph.D., Managing Director, Ebola Rapid Assay Development Consortium, Pittsburgh, PA

Avi Ma’ayan, Ph.D., Professor, Department of Pharmacology and Systems Therapeutics, Icahn School of Medicine at Mount Sinai

Robert Mabry, Ph.D., Director, Protein Sciences and Antibody Technology, Jounce Therapeutics

Philip C. Mack, Ph.D., Associate Adjunct Professor, Internal Medicine, Hematology and Oncology, University of California, Davis Medical Center

Ravi Madduri, Fellow, Computation Institute, University of Chicago; Project Manager, Math and Computer Science Division, Argonne National Lab

Holden Maecker, Ph.D., Associate Professor, Microbiology and Immunology; Director, Human Immune Monitoring Center, Stanford University

Piers Mahon, Ph.D., Director Global Alliances, Cancer Commons

Kathleen Mahoney, M.D., Ph.D., Instructor, Medicine, Hematology Oncology, Beth Israel Deaconess Medical Center

Elizabeth M. Marlowe, Ph.D., D(ABMM), Technical Director, Microbiology, Kaiser Permanente, The Permanente Medical Group Regional Laboratories

Scott Marshall, Managing Partner Analytics, Precision for Medicine

Andreas Matern, Vice President, Commercial Partnerships and Innovation, BioReference Laboratories, Inc.

Marcela Valderrama Maus, M.D., Ph.D., Assistant Professor, Medicine; Director, Medical Affairs, Translational Research Program, Abramson Cancer Center, University of Pennsylvania

Chad May, Ph.D., Director, Oncology Research Unit, Pfizer

Robert McBurney, Ph.D., CEO, Accelerated Cure Project for MS

John McCarthy, CEO, ZS Genetics

Abigail McElhinny, Ph.D., Vice President, Assay and Reagent Development, Ventana

Ira Mellman, M.D., Vice President, Cancer Immunology, Genentech

Rainer Metzger, Ph.D., Vice President, Global Business Development Pharma, Qiagen GmbH

Matthew Meyer, CareDx

Jeffrey Miller, M.D., Professor, Medicine; Deputy Director; Roger L. and Lynn C. Headrick Chair in Cancer Therapeutics, University of Minnesota Cancer Center

Steve Miller, Associate Professor and Director, UCSF Clinical Microbiology Laboratory, University of California San Francisco

Adrian Moody, Ph.D., Director & Head, Design and Development Manchester, MDx Assay Development, QIAGEN

Art Morales, Ph.D., Vice President, Technology and Corporate Development, Beryllium

Stu Morton, Ph.D., Research Scientist, LRL IT Health Informatics, Eli Lilly and Company

Michelle Munson, CEO & Co-Founder, Aspera, an IBM Company

Pamela N. Munster, M.D., Professor, Medicine, Program Leader Development Therapeutics, Director, Early Phase Clinical Trials' Program, Helen Diller Cancer Center, University of California, San Francisco Statistical Analysis of PDX Studies and Preclinical Phase-II-Like Trials (PP2T) at EMD Serono

Muhammed Murtaza, Research Assistant Professor, Co-Leader, Center for Non-Invasive Diagnostics, Translational Genomics Research Institute

Mark A. Musen, Ph.D., Professor of Biomedical Informatics, Stanford University

Lincoln Nadauld, M.D., Intermountain Health

Sunitha Nagrath, Ph.D., Assistant Professor, Chemical Engineering, University of Michigan

Peter L. Nagy, M.D., Ph.D., Assistant Professor, Pathology and Cell Biology; Director, Clinical Next Generation Sequencing, Laboratory of Personalized Genomic Medicine

Brad Nelson, Ph.D., Director, Deeley Research Centre, BC Cancer Agency

Olivier Nolan-Stevaux, Ph.D., Senior Scientist, Oncology Research, Amgen, Inc.

Susan Novak-Weekley, Ph.D., D(ABMM), Director, Microbiology, Molecular Infectious Disease & Serology Testing, Southern California Permanente Medical Group

Natko Nuber, Ph.D., Lab head, Novartis Biologics, Novartis

Mark E. Nunes, M.D., Associate Professor, Pediatrics, Division Chief, Medical Genetics, Kaiser Permanente

Pankaj Oberoi, Scientific Director, Meso Scale Discovery

Petr Obrdlik, Functional Lead, Novartis Biologics Process R&D

John O'Leary, M.D., Ph.D., Chair, Pathology, Trinity College Dublin; Director, Pathology, Coombe Women and Infants University Hospital; Consultant, Pathologist, St. James’s Hospital; Principal Investigator, Biomedical Diagnostics Institute (BDI)

Geoff Otto, Ph.D., Senior Director, Molecular Biology & Sequencing, Foundation Medicine

Aydogan Ozcan, Ph.D., Electrical Engineering Department, Bioengineering Department, California NanoSystems Institute, University of California, Los Angeles

Liron Pantanowitz, M.D., Associate Professor, Pathology & Biomedical Informatics; Director, Pathology Informatics and UPMC Shadyside Cytology Divisions; Director, the Pathology Informatics Fellowship Program, University of Pittsburgh Medical Center

Klaus Pantel, M.D., Professor and Founding Director, Institute of Tumor Biology, University, Medical Center Hamburg-Eppendorf

Pamela Paris, Ph.D., Professor, Urology, University of California, San Francisco

Abhijit Patel, M.D., Ph.D., Assistant Professor, Yale University School of Medicine

Kamlesh Patel, Ph.D., Manager, Advance Systems Engineering and Deployment, Sandia National Labs

Rudi Pauwels, CEO, Biocartis

Cloud P. Paweletz, Ph.D., Head, Translational Research Laboratory; Biomarker Lead, Belfer Institute for Applied Cancer Science, Dana Farber Cancer Institute

Pablo Perez-Pinera, M.D., Ph.D., Assistant Professor, Department of Bioengineering, University of Illinois at Urbana-Champaign

Brad Perkins, M.D., MBA, CMO, Human Longevity, Inc.

German Pihan, M.D., Staff Pathologist and Director, Diagnostic Hematopathology Service, Department of Pathology, Beth Israel Deaconess Medical Center

Angel Pizarro, Senior Solutions Architect, Amazon Web Services

Jamie L Platt, Ph.D., Vice President, Genomic Solutions, Molecular Pathology Laboratory Network, Inc.

Chris Polage, Director of Clinical Microbiology Laboratory, Department of Pathology and Laboratory Medicine, UC Davis Medical Center

Kristin Pothier, Partner, Ernst & Young LLP, United States

Matthew Porteus, M.D., Ph.D., Associate Professor, Pediatrics, Stanford University School of Medicine

Murali Prahalad, Ph.D., President & CEO, Epic Sciences

Victoria M. Pratt, Ph.D., FACMG, Director, Pharmacogenomics Laboratory, Medical and Molecular Genetics, Indiana University School of Medicine

Corrado Priami, Ph.D., Computer Science, Microsoft Research - University of Trento Centre for Computational and Systems Biology (COSBI)

Nathan D. Price, Ph.D., Professor and Associate Director, Institute for Systems Biology

Miguel E. Quinones-Mateu, Ph.D., Associate Professor & Scientific Director, University Hospitals Case Medical Center/Case Western Reserve University

Stanley Radio, Director, Cytopathology Lab & Cytotechnology, University of Nebraska

Derek Raghavan, M.D., Ph.D., FACP, FRACP, FASCO, President, Levine Cancer Institute, Carolinas HealthCare System; Professor, Medicine, University of North Carolina School of Medicine

David H. Raulet, Ph.D., C.H. Li Professor of Immunology and Pathogenesis; Co-Chair, Department of Molecular and Cell Biology, University of California, Berkley

Divyaa Ravishankar, MS, Senior Consultant, Life Sciences, Frost & Sullivan

David Rawlings, M.D., Director, Center for Immunity and Immunotherapies Seattle Children's Research Institute; Professor of Pediatrics and Immunology University of Washington School of Medicine

Mary Redman, Ph.D., Lead Statistician, Lung Cancer Committee Southwest Oncology Group, Lead Statistician, Lung Map Trial, Fred Hutchinson Cancer Research Center

Andreas Reinisch, M.D., Ph.D., Institute for Stem Cell Biology and Regenerative Medicine (ISCBRM), Stanford University

Andrew D. Rhim, M.D., Assistant Professor, Internal Medicine, Division of Gastroenterology, University of Michigan

Katherine Richardson, Ph.D., Vice President, Research & Development, Transgenomic, Inc

Gregory Richmond, Ph.D., Principal Scientist, Ibis Biosciences, Abbott

David L. Rimm, M.D., Ph.D., Professor, Pathology, Yale University

Kirk Ririe, CEO, BioFire Defense

Margo Roberts, Ph.D., CSO, Kite Pharma, Inc.

Daniel H. Robertson, Ph.D., Visiting Science Fellow, Indiana Biosciences Research Institute

Scott Rodig, M.D., Ph.D., Hematopathologist, Pathology, Brigham and Women’s Hospital

Gustavo Kunde Rohde, Ph.D., Associate Professor, Departments of Biomedical Engineering, Electrical and Computer Engineering, and Computational Biology, Carnegie Mellon University

Mark Roskey, Vice President and General Manager, Quanterix

Jason Ross, Ph.D., Research Scientist, Preventative Health Flagship, CSIRO

Mollie Roth, Managing Partner, PGx Consulting

Adrian G. Sacher, M.D., Research Fellow, Medicine, Dana Farber Cancer Institute

Mohamed Salama, M.D., Professor, Pathology, University of Utah; Director, Hematopathology Fellowship Program; Directory, Immunohistochemistry and Digital Imaging, ARUP Reference Lab

Stephen Salipante, M.D., Ph. D, Assistant Professor, Director of Next-Generation Sequencing Analytics Laboratory, Assistant Director of Molecular Diagnosis Section, University of Washington

Lidia C. Sambucetti, Ph.D., Senior Program Director, Biosciences Division, SRI International

Sabita Sankar, Ph.D., Director, Business Development, Biodesix

Avni B. Santani, Ph.D., Assistant Professor, Clinical Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia

Marc Salit, Ph.D., Leader, Genome-Scale Measurements Group, NIST Material Measurement Lab, NIST-JIMB; Consulting Professor, Department of Bioengineering, Stanford University

Kurt Schalper, M.D., Ph.D., Associate Research Scientist, Pathology, Yale School of Medicine

Sabine Schefzick, Ph.D., Senior Manager, Oncology & West Coast R&D Business Technology, Pfizer

Howard I. Scher, M.D., Chief, Genitourinary Oncology & Solid Tumor Medicine, Memorial Sloan Kettering Cancer Center

Richard L. Schilsky, M.D., FASCO, CMO, American Society of Clinical Oncology

Richard Schlegel, M.D., Ph.D., Professor and Oscar B. Hunter Chair, Pathology; Director, Center for Cell Reprogramming, Georgetown University Medical School

Cecilia Schott, MBA, Head, Personalized Healthcare, Corporate Development & Ventures, AstraZeneca

Stephan C. Schürer, Ph.D., Department of Molecular and Cellular Pharmacology, Miller School of Medicine, University of Miami

Anil Sethi, CEO, Founder, Gliimpse

Ajay Shah, Ph.D., MBA, PMP, Division Director, Research Informatics and Systems, City of Hope National Medical Center

Hemanth Shenoi, Ph.D., Vice President, Business Development and Diagnostics, LucigenDx

Tara Sigdel, Ph.D., Assistant Professor, Surgery, University of California San Francisco School of Medicine

Veena Singh, Senior Vice President & Medical Director, Biocept, Inc.

John J. Sninsky, Ph.D. CSO, CareDx

Chen Song, Ph.D., Research Fellow, Dana-Farber Cancer Institute, Harvard Medical School

Erik Sontheimer, Ph.D., Professor, RNA Therapeutics Institute and the Program in Molecular Medicine, University of Massachusetts Medical School

Steven A. Soper, Ph.D., Professor, Biomedical Engineering & Chemistry; Associate Editor, Analyst; Director, Center for BioModular Multiscale Systems, University of North Carolina

Jorge Soto, Co-founder and CTO, Miroculus

Eugene (Gene) Spier, Ph.D., Director, Bioinformatics, Roche Molecular Systems

Linda Starr-Spires, Ph.D., Director, Nucleic Acid Methods, Global Clinical Immunology, Sanofi Pasteur, Inc.

Joshua M. Stuart, Ph.D., Baskin Engineering Endowed Chair & Professor, Biomolecular Engineering; Associate Director, Center for Biomolecular Science and Engineering, University of California, Santa Cruz

Samantha Swarbrick, Ph.D., Student, Mechanical and Manufacturing Engineering, Loughborough University

Frederic Sweeney, Ph.D. Senior Director, Business Development T2 Biosystems

Janis M. Taube, M.D., MSc, Director, Dermatopathology; Assistant Professor, Dermatology and Pathology, Johns Hopkins

J. Marty Tenenbaum, Ph.D., Chairman, Cancer Commons

Michael Thiele, Ph.D., Manager R&D, Research & Innovation, Baxalta Innovations GmbH

John Todd, Professor, Medical Genetics, University of Cambridge; JDRF/Wellcome Trust Diabetes and Inflammation Laboratory, NIHR Cambridge Biomedical Research Centre, Cambridge Institute for Medical Research, University of Cambridge

John E. Tomaszewski, M.D., MASCP, Professor and Chair, Pathology and Anatomical Sciences, School of Medicine and Biomedical Sciences, State University of New York at Buffalo

Scott A. Tomlins, M.D., Ph.D., Assistant Professor, Pathology & Urology, University of Michigan

Hsian-Rong Tseng, Ph.D., Professor, Molecular & Medical Pharmacology; Member, JCCC Cancer Molecular Imaging; Faculty, Crump Institute for Molecular Imaging, University of California, Los Angeles

Paul Tumeh, M.D., Assistant Professor, Department of Medicine, University of California Los Angeles

James W. Tunnell, Ph.D., Associate Professor, Biomedical Engineering, The University of Texas, Austin

Katherine Tynan Ph.D., Tynan Consulting LLC

Duygu Ucar, Ph.D., Assistant Professor, Genomic Medicine, Jackson Laboratory

Victor Velculescu, M.D., Ph.D., Professor, Oncology; Co-Director, Cancer Biology, Johns Hopkins Sidney Kimmel Cancer Center; Co-Founder, Personal Genome Diagnostics

Rebecca M. Walker, Vice President, Global Sales & Marketing, Glencoe Software

Kai Wang, Principal Scientist, Institute for Systems Biology

Ping Wang, Ph.D., Director, Clinical Chemistry, Pathology and Genomic Medicine, Houston Methodist Hospital

Andrew D. Weinberg, Ph.D., Chief, Laboratory of Basic Immunology, Providence Cancer Center

George M. Weinstock, Ph.D., Professor and Associate Director, Jackson Laboratory for Genomic Medicine

James W. Welsh, M.D., Associate Professor, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center

Francis White, EU General Manager, AliveCor Ltd.

David C. Wilbur, M.D., Professor, Pathology, Massachusetts General Hospital

Juliet Williams, Ph.D., Head, Oncology Drug Discovery, Novartis Institute for Biomedical Research

P. Mickey Williams, Ph.D., Director, Molecular Characterization & Clinical Assay Development Laboratory (MoCha), Frederick National Laboratory for Cancer Research

Liz Worthey, Ph.D., Chief Informatics & Product Development Officer, Envision Genomics

Ignasio I. Wistuba, M.D., Chair, Translational Molecular Pathology, Division of Pathology/Lab Medicine; Anderson Clinical Faculty Chair, Cancer Treatment and Research, The University of Texas MD Anderson Cancer Center

Carl Wittwer, Ph.D., University of Utah

Alan Wu, Ph.D., Director, Pharmacogenomics Laboratory, University of California, San Francisco (UCSF); Professor, Department of Lab Medicine, University of California, San Francisco

Haoquan Wu, Ph.D., Associate Professor, Department of Biomedical Sciences, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center

Xin (Cindy) Xiong, Ph.D., Research Scientist, Agenovir Corporation

Winston Yan, Graduate Student, M.D.-Ph.D. Program, Laboratory of Dr. Feng Zhang, Broad Institute of MIT and Harvard

Yaping Yang, Ph.D., Associate Professor, Molecular and Human Genetics, Baylor College of Medicine

Elsie Yu, Ph.D., DABCC, FACB, System Director, Toxicology and Point-of-Care Testing; Associate Director, Clinical Chemistry, Geisinger Medical Laboratories

Lihua Yu, Ph.D., Director of Bioinformatics, H3 Biomedicine, Inc.

Xingxing Zang, Ph.D., Associate Professor, Microbiology, Immunology and Medicine, Albert Einstein College of Medicine

Bruce R. Zetter, Ph.D. Charles Nowiszewski Professor, Cancer Biology, Surgery, Harvard Medical School

Su-Chun Zhang, M.D., Ph.D., Steenbock Professor in Behavioral and Neural Sciences and Professor of Neuroscience and Neurology Waisman Center, University of Wisconsin

Grace Zhao, Ph.D., Co-Founder and Director of Research, AccuraGen

Weian Zhao, Ph.D., Assistant Professor, Department of Pharmaceutical Sciences, Sue and Bill Gross Stem Cell Research Center, Chao Family Comprehensive Cancer Center, Edwards Lifesciences Center for Advanced Cardiovascular Technology, Department of Biomedical Engineering, University of California Irvine

Siyang Zheng, Ph.D., Associate Professor, Biomedical Engineering, Pennsylvania State University

Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag  

Premier Sponsors:  

Bina Technologies




Jackson Laboratory 




 Precision for Medicine 





Silicon Biosystems



ThermoFisher Scientific

Thomson Reuters